2,5,8,11,14,17,20-Heptaoxadocosane-22-thiol

Catalog No.: 
ACMLVA509
CAS No.: 
651042-82-9
Molecular Formula: 
C15H32O7S
Molecular Weight: 
356.48
2,5,8,11,14,17,20-Heptaoxadocosane-22-thiol structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g98%$107.00In stockInquiry
5g98%$393.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2,5,8,11,14,17,20-Heptaoxadocosane-22-thiol
IUPAC Name2,5,8,11,14,17,20-heptaoxadocosane-22-thiol
MDL No.MFCD08274612
Molecular FormulaC15H32O7S
Molecular Weight356.48
SMILESCOCCOCCOCCOCCOCCOCCOCCS
InChI KeyPVSKDHZQTUFAEZ-UHFFFAOYSA-N
SynonymCS-0044653 | BP-22085 | SB67195 | alpha-Methoxy-omega-mercapto hepta(ethylene glycol) | MFCD08274612 | mPEG7-SH | 2-[2-[2-[2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanethiol | HY-W052006 | AS-78344 | E78579 | BCP11352 | DTXSID40584839
CAS No.651042-82-9
PubChem CID16218250

Safety Data

Pictogram
Health hazardEnvironmental hazardHarmful or irritant
Signal Word
Danger
Hazard Statement(s)
H315-H319-H372-H413
Precautionary Statement(s)
P264-P273-P280-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACMLVA509 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACMLVA509 route product structure diagram
    ACMLVA509651042-82-9In Stock
Inquiry

2. ACMLVA509 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACMLVA509 route product structure diagram
    ACMLVA509651042-82-9In Stock
Inquiry

3. ACMLVA509 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACMLVA509 route product structure diagram
    ACMLVA509651042-82-9In Stock
Inquiry

Comments (0)